Pauleit Dirk, Zimmermann Andre, Stoffels Gabriele, Bauer Dagmar, Risse Jörn, Flüss Michael O, Hamacher Kurt, Coenen Heinz H, Langen Karl-Josef
Institute of Medicine and Brain Imaging Center West, Research Center Jülich, Jülich, Germany.
J Nucl Med. 2006 Feb;47(2):256-61.
Recent studies suggest a somewhat selective uptake of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) in cerebral gliomas and in squamous cell carcinoma (SCC) and a good distinction between tumor and inflammation. The aim of this study was to investigate the diagnostic potential of 18F-FET PET in patients with SCC of the head and neck region by comparing that tracer with 18F-FDG PET and CT.
Twenty-one patients with suspected head and neck tumors underwent 18F-FET PET, 18F-FDG PET, and CT within 1 wk before operation. After coregistration, the images were evaluated by 3 independent observers and an ROC analysis was performed, with the histopathologic result used as a reference. Furthermore, the maximum standardized uptake values (SUVs) in the lesions were determined.
In 18 of 21 patients, histologic examination revealed SCC, and in 2 of these patients, a second SCC tumor was found at a different anatomic site. In 3 of 21 patients, inflammatory tissue and no tumor were identified. Eighteen of 20 SCC tumors were positive for both 18F-FDG uptake and 18F-FET uptake, one 0.3-cm SCC tumor was detected neither with 18F-FDG PET nor with 18F-FET PET, and one 0.7-cm SCC tumor in a 4.3-cm ulcer was overestimated as a 4-cm tumor on 18F-FDG PET and missed on 18F-FET PET. Inflammatory tissue was positive for 18F-FDG uptake (SUV, 3.7-4.7) but negative for 18F-FET uptake (SUV, 1.3-1.6). The SUVs of 18F-FDG in SCC were significantly higher (13.0 +/- 9.3) than those of 18F-FET (4.4 +/- 2.2). The ROC analysis showed significantly superior detection of SCC with (18)F-FET PET or 18F-FDG PET than with CT. No significant difference (P = 0.71) was found between 18F-FDG PET and 18F-FET PET. The sensitivity of 18F-FDG PET was 93%, specificity was 79%, and accuracy was 83%. 18F-FET PET yielded a lower sensitivity of 75% but a substantially higher specificity of 95% (accuracy, 90%).
18F-FET may not replace 18F-FDG in the PET diagnostics of head and neck cancer but may be a helpful additional tool in selected patients, because 18F-FET PET might better differentiate tumor tissue from inflammatory tissue. The sensitivity of 18F-FET PET in SCC, however, was inferior to that of 18F-FDG PET because of lower SUVs.
近期研究表明,O-(2-[18F]氟乙基)-L-酪氨酸(FET)在脑胶质瘤和鳞状细胞癌(SCC)中存在一定程度的选择性摄取,且在肿瘤与炎症之间有良好的区分度。本研究旨在通过将该示踪剂与18F-FDG PET及CT进行比较,探讨18F-FET PET对头颈部区域鳞状细胞癌患者的诊断潜力。
21例疑似头颈部肿瘤患者在术前1周内接受了18F-FET PET、18F-FDG PET及CT检查。图像配准后,由3名独立观察者进行评估,并以组织病理学结果为参考进行ROC分析。此外,还测定了病变部位的最大标准化摄取值(SUV)。
21例患者中,18例经组织学检查确诊为SCC,其中2例在不同解剖部位发现了第二个SCC肿瘤。21例患者中有3例未发现肿瘤,仅见炎性组织。20例SCC肿瘤中有18例对18F-FDG摄取和18F-FET摄取均呈阳性,1例0.3 cm的SCC肿瘤在18F-FDG PET和18F-FET PET检查中均未被检测到,1例位于4.3 cm溃疡内的0.7 cm SCC肿瘤在18F-FDG PET上被高估为4 cm肿瘤,而在18F-FET PET上未被发现。炎性组织对18F-FDG摄取呈阳性(SUV,3.7 - 4.7),但对18F-FET摄取呈阴性(SUV,1.3 - 1.6)。SCC中18F-FDG的SUV(13.0±9.3)显著高于18F-FET(4.4±2.2)。ROC分析显示,(18)F-FET PET或18F-FDG PET对SCC的检测明显优于CT。18F-FDG PET与18F-FET PET之间未发现显著差异(P = 0.71)。18F-FDG PET的敏感性为93%,特异性为79%,准确性为83%。18F-FET PET的敏感性较低,为75%,但特异性显著更高,为95%(准确性为90%)。
在头颈部癌的PET诊断中,18F-FET可能无法取代18F-FDG,但对于部分患者可能是一种有用的辅助工具,因为18F-FET PET可能更有助于区分肿瘤组织与炎性组织。然而,由于SUV较低,18F-FET PET在SCC中的敏感性低于18F-FDG PET。